نتایج جستجو برای: drug efflux transporters

تعداد نتایج: 620624  

Journal: :archives of trauma research 0
patrick t. ronaldson department of medical pharmacology, university of arizona college of medicine, tucson, usa; department of medical pharmacology, college of medicine, university of arizona, tucson, az, usa , +1-5206262173 thomas p. davis department of medical pharmacology, university of arizona college of medicine, tucson, usa

2007
Sumio OHTSUKI Mayu KAMOI Yuki WATANABE Hiroya SUZUKI Satoko HORI Tetsuya TERASAKI

family transport various substrates coupled with hydrolysis of ATP. The human ABC transporter superfamily consists of 49 subtypes, some of which function as drug efflux transporters (ABCB1, ABCC subfamily and ABCG2) or sterol transporters (ABCA1, ABCA7, ABCG1, ABCG5 and ABCG8). However, the role of the ABCA5-like transporters remains largely unknown. The ABCA family forms the second largest gen...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2002
Feng R Luo Pankaj V Paranjpe Ailan Guo Eric Rubin Patrick Sinko

Irinotecan (CPT-11) is a water-soluble camptothecin (CPT) derivative that has been recently approved in the United States for patients as a first-line therapy in advanced colorectal cancer. Phase I clinical trials using oral CPT-11 have shown poor and variable oral bioavailability. The present study was designed to investigate the intestinal absorption and efflux mechanisms of CPT-11 using in v...

Journal: :Antimicrobial agents and chemotherapy 2013
Hui Xin Ong Daniela Traini Mary Bebawy Paul M Young

Ciprofloxacin is a well-established broad-spectrum fluoroquinolone antibiotic that penetrates well into the lung tissues; still, the mechanisms of its transepithelial transport are unknown. The contributions of specific transporters, including multidrug efflux transporters, organic cation transporters, and organic anion-transporting polypeptide transporters, to the uptake of ciprofloxacin were ...

2016
Yuming Wei Daniel C. Poon Rong Fei Amy S. M. Lam Steve C. F. Au-Yeung Kenneth K. W. To

Three molecular targeted tyrosine kinase inhibitors (TKI) were conjugated to classical platinum-based drugs with an aim to circumvent TKI resistance, predominately mediated by the emergence of secondary mutations on oncogenic kinases. The hybrids were found to maintain specificity towards the same oncogenic kinases as the original TKI. Importantly, they are remarkably less affected by TKI resis...

Journal: :PloS one 2016
S M D K Ganga Senarathna Madhu Page-Sharp Andrew Crowe

The combination of passive drug permeability, affinity for uptake and efflux transporters as well as gastrointestinal metabolism defines net drug absorption. Efflux mechanisms are often overlooked when examining the absorption phase of drug bioavailability. Knowing the affinity of antimalarials for efflux transporters such as P-glycoprotein (P-gp) may assist in the determination of drug absorpt...

Journal: :British journal of pharmacology 2013
Kenneth K W To Brian Tomlinson

BACKGROUND AND PURPOSE Multidrug resistance (MDR), usually mediated by overexpression of efflux transporters such as P-gp, ABCG2 and/or MRP1, remains a major obstacle hindering successful cancer chemotherapy. There has been great interest in the development of inhibitors towards these transporters to circumvent resistance. However, since the inhibition of transporter is not specific to cancer c...

2014
Thomas Eicher Markus A Seeger Claudio Anselmi Wenchang Zhou Lorenz Brandstätter François Verrey Kay Diederichs José D Faraldo-Gómez Klaas M Pos

Membrane transporters of the RND superfamily confer multidrug resistance to pathogenic bacteria, and are essential for cholesterol metabolism and embryonic development in humans. We use high-resolution X-ray crystallography and computational methods to delineate the mechanism of the homotrimeric RND-type proton/drug antiporter AcrB, the active component of the major efflux system AcrAB-TolC in ...

2005
Wolfgang Löscher

Despite the use of new antiepileptic drugs, approximately one third of patients with epilepsy have seizures that cannot be controlled satisfactorily by medical treatment. Drug resistance may exist at the time of the first seizure or may develop later as result of the disease process. The mechanisms of these different scenarios are likely to be multifactorial, and may include alterations in brai...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید